* Lifestance Health Group Inc LFST.OQ LFST.O is expected
to show a rise in quarterly revenue when it reports results on
February 28 for the period ending December 31 2023
* The Scottsdale Arizona-based company is expected to
report a
14.6% increase in revenue to $263.003 million from $229.4
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Lifestance Health Group
Inc is
for a loss of 9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Lifestance
Health
Group Inc is $8.00, above its last closing price of $6.23.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.08 -0.08 -0.17 Missed -112.5
Jun. 30 2023 -0.09 -0.09 -0.13 Missed -50
Mar. 31 2023 -0.11 -0.11 -0.09 Beat 16.3
Dec. 31 2022 -0.13 -0.13 -0.13 Met -1.3
Sep. -0.13 -0.14 -0.11 Beat 20.5
30 2022
Jun. 30 2022 -0.15 -0.14 -0.19 Missed -35.7
Mar. 31 2022 -0.20 -0.17 -0.18 Missed -4.7
Dec. 31 2021 -0.20 -0.21 -0.33 Missed -55.9
This summary was machine generated February 26 at 13:40 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)